20xx年醫(yī)學(xué)專題—急性冠脈綜合征評(píng)估及危險(xiǎn)分層-預(yù)覽頁(yè)
【正文】 ays Elev Cardiac Markers (CKMB or troponin),4.7,8.3,13.2,19.9,26.2,40.9,0,10,20,30,40,50,0/1,2,3,4,5,6/7,D/MI/Urg Revasc (%),Number of Risk Factors,Population (%):,4.3,17.3,32.0,29.3,13.0,3.4,C Statistic=0.65 c2 trend P.001,第七頁(yè)，共二十二頁(yè)。38:478485.,第九頁(yè)，共二十二頁(yè)。343:11391147. (with permission),Predictive Value of Troponin T and hsCRP for Mortality from ACS in FRISC Substudy,20,10,0,0,6,12,18,24,30,36,42,48,Cumulative Probability of Death (%),Months,Troponin T 0.60 181。,Risk Stratification With CRP and Troponin T,Morrow DA, et al. J Am Coll Cardiol. 1998。,Btype Natriuretic Peptide (BNP) and Mortality in ACS Patients,de Lemos JA, et al. N Engl J Med. 2001。,Multimarker Approach: Troponin I, CRP, and BNP to Predict 30Day Mortality in ACS,Sabatine M, et al. Circulation. 2002。108:10491052. (with permission),Clinical Investigation Reports,Soluble CD40L Risk Prediction After Acute Coronary Syndromes,,3.5,3,2.5,2,1.5,1,0.5,0,Death,MI,DIMI,CHF,DIMI CHF,Hazard Ratios (HR),*,*,*,?,?,?,*P.01 compared to first quartile ?P.03 compared to first quartile,第十七頁(yè)，共二十二頁(yè)。12:7482. (with permission),第十九頁(yè)，共二十二頁(yè)。108:250252.,Multimarker Strategy in ACS,第二十一頁(yè)，共二十二頁(yè)。Death/MI/RI。CRP 2mg/l (n=314)
環(huán)評(píng)公示相關(guān)推薦
鄂ICP備17016276號(hào)-1